163 related articles for article (PubMed ID: 17581190)
1. Progress in suplatast tosilate research.
Sano Y; Yamada H
Clin Exp Allergy; 2007 Jul; 37(7):970-2. PubMed ID: 17581190
[No Abstract] [Full Text] [Related]
2. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
4. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
[No Abstract] [Full Text] [Related]
6. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
7. 7. Control of allergic airway inflammation through immunomodulation.
Corry DB; Kheradmand F
J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S461-4. PubMed ID: 16455347
[TBL] [Abstract][Full Text] [Related]
8. [Cough-variant asthma successfully treated with suplatast tosilate].
Fujimori K; Suzuki E; Arakawa M
Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
[No Abstract] [Full Text] [Related]
9. Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects.
Agrawal DK; Cheng G; Kim MJ; Kiniwa M
Clin Exp Allergy; 2008 Feb; 38(2):305-12. PubMed ID: 18028459
[TBL] [Abstract][Full Text] [Related]
10. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
Hsu LW; Yang CH; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Tsao FK; Chen CL
Transpl Immunol; 2007 Nov; 18(2):108-14. PubMed ID: 18005853
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
12. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
[TBL] [Abstract][Full Text] [Related]
13. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
14. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
15. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
Yamasawa H; Oshikawa K; Sugiyama Y
Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
Yamada Y; Yoshihara S; Arisaka O
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
[No Abstract] [Full Text] [Related]
17. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
[TBL] [Abstract][Full Text] [Related]
18. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
19. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
[TBL] [Abstract][Full Text] [Related]
20. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
Mizuguchi H; Orimoto N; Kadota T; Kominami T; Das AK; Sawada A; Tamada M; Miyagi K; Adachi T; Matsumoto M; Kosaka T; Kitamura Y; Takeda N; Fukui H
J Pharmacol Sci; 2016 Mar; 130(3):151-8. PubMed ID: 26874672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
